Laurent Désaubry CNRS director of research
Course and current status
Dr Laurent Désaubry is a CNRS Director of Research at the Center of Research in Biomedicine of Strasbourg affiliated to the University of Strasbourg and INSERM (website: http://desaubry.u-strasbg.fr/). After a Ph.D. degree in medicinal chemistry and postdoctoral internship at SUNY at Stony Brook (USA) he joined CNRS as Research Senior Scientist at the University of Strasbourg. He was promoted CNRS research director (corresponds to full professor) in 2014, and was appointed adjunct professor at Tianjin University of Science and Technology from 2015 to 2019. He is serving as an editorial board member of Frontiers in Chemistry, Medicinal Chemistry, and International Journal of Molecular Science. His research covers medicinal chemistry of prohibitin ligands and prokineticin receptor agonists.
Scientific summary
Dr Laurent Désaubry is a CNRS Director of Research at the Center of Research in Biomedicine of Strasbourg affiliated to the University of Strasbourg and INSERM (website: http://desaubry.u-strasbg.fr/). After a Ph.D. degree in medicinal chemistry and postdoctoral internship at SUNY at Stony Brook (USA) he joined CNRS as Research Senior Scientist at the University of Strasbourg. He was promoted CNRS research director (corresponds to full professor) in 2014, and was appointed adjunct professor at Tianjin University of Science and Technology from 2015 to 2019. He is serving as an editorial board member of Frontiers in Chemistry, Medicinal Chemistry, and International Journal of Molecular Science. His research covers medicinal chemistry of prohibitin ligands and prokineticin receptor agonists.
He also co-founded with Dr Stéphan Vagner (Institut Curie) and Pr Caroline Robert (Gustave Roussy) the start-up Ribonexus that aims at developing inovative treatments against chemoresistant cancers (https://ribonexus-project.com/).
